PGT Healthcare Aims To Unlock Value Of Existing Portfolios
This article was originally published in The Tan Sheet
Executive Summary
PGT Healthcare CEO Briain de Buitleir and COO Eli Shani say the joint venture will help Teva realize greater value for its localized OTCs and enable Procter & Gamble to expand its nutritional products portfolio.
You may also be interested in...
Teva Seeds OTC Growth Synergies With Former Allergan Business
Teva's opportunity to compete in the US OTC drug market now that the Allergan's generic nonprescription products are under its roof makes company "more excited" about the space "than we have ever been," says CEO Sigurdur Olaf Olaffson,
Teva Seeds OTC Growth Synergies With Former Allergan Business
Teva's opportunity to compete in the US OTC drug market now that the Allergan's generic nonprescription products are under its roof makes company "more excited" about the space "than we have ever been," says CEO Sigurdur Olaf Olaffson,
Teva Gives OTCs “Major” Role In 2014 Outlook
The Israeli firm reassures investors that the business is stable and is moving forward with strategic plans after the abrupt exit of its CEO. Teva’s OTC business will be a key driver of those plans, says interim CEO Eyal Desheh.